Intensity Therapeutics upsizes proposed IPO to $15M from $8M (INTS) Finances May 19, 2023 [ad_1] Andrey Tolkachev Oncology drug developer Depth Therapeutics (NASDAQ:INTS) has upsized its proposed preliminary public providing to $15M from $8M.…
